{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:05:06Z","timestamp":1649124306007},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orthop\u00e4de"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00132-019-03811-9","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T07:02:46Z","timestamp":1568790166000},"page":"905-910","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Haut und Rheuma"],"prefix":"10.1007","volume":"48","author":[{"given":"S.","family":"St\u00e4nder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Tha\u00e7i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"3811_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","volume":"26","author":"E Christophers","year":"2001","unstructured":"Christophers\u00a0E (2001) Psoriasis\u2014epidemiology and clinical spectrum. Clin Exp Dermatol 26:314\u2013320","journal-title":"Clin Exp Dermatol"},{"key":"3811_CR2","doi-asserted-by":"publisher","first-page":"808","DOI":"10.2340\/00015555-2672","volume":"97","author":"A Egeberg","year":"2017","unstructured":"Egeberg\u00a0A, Skov\u00a0L, Gislason\u00a0GH, Thyssen\u00a0JP, Mallbris\u00a0L (2017) Incidence and prevalence of psoriasis in Denmark. Acta Derm Venereol 97:808\u2013812","journal-title":"Acta Derm Venereol"},{"key":"3811_CR3","first-page":"48","volume":"12","author":"M Augustin","year":"2014","unstructured":"Augustin\u00a0M et\u00a0al (2014) German psoriasis registry PsoBest: objectives, methodology and baseline data. J\u00a0Dtsch Dermatol Ges 12:48\u201357","journal-title":"J Dtsch Dermatol Ges"},{"key":"3811_CR4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s11926-006-0064-9","volume":"8","author":"P Mease","year":"2006","unstructured":"Mease\u00a0P (2006) Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology. Curr Rheumatol Rep 8:348\u2013354","journal-title":"Curr Rheumatol Rep"},{"key":"3811_CR5","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1365-2133.2008.09023.x","volume":"160","author":"K Reich","year":"2009","unstructured":"Reich\u00a0K, Kr\u00fcger\u00a0K, M\u00f6ssner\u00a0R, Augustin\u00a0M (2009) Epidemiology and clinical pattern of psoriatic arthritis in Germany: a\u00a0prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 160:1040\u20131047","journal-title":"Br J Dermatol"},{"key":"3811_CR6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","volume":"68","author":"AW Armstrong","year":"2013","unstructured":"Armstrong\u00a0AW, Harskamp\u00a0CT, Armstrong\u00a0EJ (2013) Psoriasis and metabolic syndrome: a\u00a0systematic review and meta-analysis of observational studies. J\u00a0Am Acad Dermatol 68:654\u2013662","journal-title":"J Am Acad Dermatol"},{"key":"3811_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2133.2006.07562.x","volume":"156","author":"RJ Ludwig","year":"2007","unstructured":"Ludwig\u00a0RJ et\u00a0al (2007) Psoriasis: a\u00a0possible risk factor for development of coronary artery calcification. Br J Dermatol 156:271\u2013276","journal-title":"Br J Dermatol"},{"key":"3811_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/1203475415602842","volume":"20","author":"YC Lai","year":"2016","unstructured":"Lai\u00a0YC, Yew\u00a0YW (2016) Psoriasis as an independent risk factor for cardiovascular disease: an epidemiologic analysis using a\u00a0national database. J\u00a0Cutan Med Surg 20:327\u2013333","journal-title":"J Cutan Med Surg"},{"key":"3811_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jaad.2017.08.034","volume":"77","author":"L Kwa","year":"2017","unstructured":"Kwa\u00a0L, Kwa\u00a0MC, Silverberg\u00a0JI (2017) Cardiovascular comorbidities of pediatric psoriasis among hospitalized children in the United States. J\u00a0Am Acad Dermatol 77:1023\u20131029","journal-title":"J Am Acad Dermatol"},{"key":"3811_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jaad.2013.09.020","volume":"70","author":"J Hugh","year":"2014","unstructured":"Hugh\u00a0J et\u00a0al (2014) From the medical board of the National Psoriasis Foundation: the risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. J\u00a0Am Acad Dermatol 70:168\u2013177","journal-title":"J Am Acad Dermatol"},{"key":"3811_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1529-8019.2007.00112.x","volume":"20","author":"M Lawry","year":"2007","unstructured":"Lawry\u00a0M (2007) Biological therapy and nail psoriasis. Dermatol Ther 20:60\u201367","journal-title":"Dermatol Ther"},{"issue":"Suppl 1","key":"3811_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000316171","volume":"221","author":"D McGonagle","year":"2010","unstructured":"McGonagle\u00a0D, Palmou Fontana\u00a0N, Tan\u00a0AL, Benjamin\u00a0M (2010) Nailing down the genetic and immunological basis for psoriatic disease. Dermatology (Basel) 221(Suppl 1):15\u201322","journal-title":"Dermatology (Basel)"},{"key":"3811_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00105-016-3784-4","volume":"67","author":"S St\u00e4nder","year":"2016","unstructured":"St\u00e4nder\u00a0S, St\u00e4nder\u00a0M, Thomas\u00a0P, Prinz\u00a0JC, Wolf\u00a0R (2016) Psoriasis migrans: erythema migrans as Koebner phenomenon in psoriasis. Hautarzt 67:549\u2013552","journal-title":"Hautarzt"},{"key":"3811_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes\u00a0JE, Chan\u00a0TC, Krueger\u00a0JG (2017) Psoriasis pathogenesis and the development of novel targeted immune therapies. J\u00a0Allergy Clin Immunol 140:645\u2013653","journal-title":"J Allergy Clin Immunol"},{"key":"3811_CR15","unstructured":"Trense\u00a0Y, Tha\u00e7i\u00a0D Biologicals in der Behandlung von Psoriasis. Pharmakon 7(1):42\u201349"},{"key":"3811_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00105-016-3925-9","volume":"68","author":"F Behrens","year":"2017","unstructured":"Behrens\u00a0F, Tha\u00e7i\u00a0D, Wollenhaupt\u00a0J, Kr\u00fcger\u00a0K (2017) Psoriatic arthritis: overview of drug therapy options and administration characteristics. Hautarzt 68:153\u2013169","journal-title":"Hautarzt"},{"key":"3811_CR17","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMra074081","volume":"358","author":"T Bieber","year":"2008","unstructured":"Bieber\u00a0T (2008) Atopic dermatitis. N\u00a0Engl J Med 358:1483\u20131494","journal-title":"N Engl J Med"},{"key":"3811_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/all.13231","volume":"73","author":"JP Thyssen","year":"2018","unstructured":"Thyssen\u00a0JP et\u00a0al (2018) Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide. Allergy 73:214\u2013220","journal-title":"Allergy"},{"key":"3811_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaci.2015.06.029","volume":"137","author":"J Schmitt","year":"2016","unstructured":"Schmitt\u00a0J et\u00a0al (2016) Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a\u00a0decreased risk for type 1 diabetes. J\u00a0Allergy Clin Immunol 137:130\u2013136","journal-title":"J Allergy Clin Immunol"},{"key":"3811_CR20","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/ng.3424","volume":"47","author":"L Paternoster","year":"2015","unstructured":"Paternoster\u00a0L et al (2015) Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat Genet 47:1449\u20131456","journal-title":"Nat Genet"},{"key":"3811_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","volume":"4","author":"S Weidinger","year":"2018","unstructured":"Weidinger\u00a0S, Beck\u00a0LA, Bieber\u00a0T, Kabashima\u00a0K, Irvine\u00a0AD (2018) Atopic dermatitis. Nat Rev Dis Primers 4:1","journal-title":"Nat Rev Dis Primers"},{"key":"3811_CR22","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1038\/jid.2008.111","volume":"128","author":"C Koga","year":"2008","unstructured":"Koga\u00a0C, Kabashima\u00a0K, Shiraishi\u00a0N, Kobayashi\u00a0M, Tokura\u00a0Y (2008) Possible pathogenic role of Th17 cells for atopic dermatitis. J\u00a0Invest Dermatol 128:2625\u20132630","journal-title":"J Invest Dermatol"},{"key":"3811_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.it.2011.08.003","volume":"32","author":"CM Wilke","year":"2011","unstructured":"Wilke\u00a0CM, Bishop\u00a0K, Fox\u00a0D, Zou\u00a0W (2011) Deciphering the role of Th17 cells in human disease. Trends Immunol 32:603\u2013611","journal-title":"Trends Immunol"},{"key":"3811_CR24","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaci.2012.02.002","volume":"129","author":"TS Tang","year":"2012","unstructured":"Tang\u00a0TS, Bieber\u00a0T, Williams\u00a0HC (2012) Does \u2018autoreactivity\u2019 play a\u00a0role in atopic dermatitis? J\u00a0Allergy Clin Immunol 129:1209\u20131215.e2","journal-title":"J Allergy Clin Immunol"},{"key":"3811_CR25","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.jid.2018.02.037","volume":"138","author":"E Guttman-Yassky","year":"2018","unstructured":"Guttman-Yassky\u00a0E, Krueger\u00a0JG (2018) IL-17C: a unique epithelial cytokine\u00a0with potential for targeting\u00a0across the spectrum of atopic dermatitis and psoriasis. J\u00a0Invest Dermatol 138:1467\u20131469","journal-title":"J Invest Dermatol"},{"key":"3811_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00105-018-4131-8","volume":"69","author":"T Werfel","year":"2018","unstructured":"Werfel\u00a0T, Wollenberg\u00a0A, Pumnea\u00a0T, Heratizadeh\u00a0A (2018) New aspects in systemic treatment of atopic dermatitis. Hautarzt 69:217\u2013224","journal-title":"Hautarzt"},{"key":"3811_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s40629-016-0110-8","volume":"25","author":"T Werfel","year":"2016","unstructured":"Werfel\u00a0T et\u00a0al (2016) S2k guideline on diagnosis and treatment of atopic dermatitis\u2014short version. Allergo J Int 25:82\u201395","journal-title":"Allergo J Int"},{"key":"3811_CR28","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","volume":"384","author":"L Lisnevskaia","year":"2014","unstructured":"Lisnevskaia\u00a0L, Murphy\u00a0G, Isenberg\u00a0D (2014) Systemic lupus erythematosus. Lancet 384:1878\u20131888","journal-title":"Lancet"},{"key":"3811_CR29","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s00105-018-4266-7","volume":"69","author":"P Moinzadeh","year":"2018","unstructured":"Moinzadeh\u00a0P, Kreuter\u00a0A, Krieg\u00a0T, Hunzelmann\u00a0N (2018) Morphea or localized scleroderma and extragenital lichen sclerosus. Hautarzt 69:892\u2013900","journal-title":"Hautarzt"},{"key":"3811_CR30","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/jdv.14458","volume":"31","author":"R Knobler","year":"2017","unstructured":"Knobler\u00a0R et al (2017) European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J\u00a0Eur Acad Dermatol Venereol 31:1401\u20131424","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3811_CR31","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00105-018-4258-7","volume":"69","author":"N Hunzelmann","year":"2018","unstructured":"Hunzelmann\u00a0N (2018) Current treatment of systemic scleroderma. Hautarzt 69:901\u2013907","journal-title":"Hautarzt"},{"key":"3811_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.clindermatol.2018.04.005","volume":"36","author":"S Florez-Pollack","year":"2018","unstructured":"Florez-Pollack\u00a0S, Kunzler\u00a0E, Jacobe\u00a0HT (2018) Morphea: Current concepts. Clin Dermatol 36:475\u2013486","journal-title":"Clin Dermatol"}],"container-title":["Der Orthop\u00e4de"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-019-03811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00132-019-03811-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-019-03811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T13:01:51Z","timestamp":1600347711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00132-019-03811-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["3811"],"URL":"https:\/\/doi.org\/10.1007\/s00132-019-03811-9","relation":{},"ISSN":["0085-4530","1433-0431"],"issn-type":[{"value":"0085-4530","type":"print"},{"value":"1433-0431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,18]]},"assertion":[{"value":"18 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0St\u00e4nder und R.\u00a0J.\u00a0Ludwig geben an, dass kein Interessenkonflikt besteht. D.\u00a0Tha\u00e7i: Pr\u00fcfarzt\/klinische Studien: Abbvie, Almiral, Amgen, Biogen-Idec, Bioskin, Boehringer-Ingelheim, BMS, Celgene, Chugai, Dermira, Dignity, Elli-Lilly, Forward-Pharma, Glaxo-Smith-Kline, Leo-Pharma, Janssen-Cilag, Maruho, Medac, MSD, Mitsubishi Pharma, Novartis, Pfizer, Regeneron, Roche, Sanofi, Sandoz-Hexal, UCB. Wissenschaftliche Vortr\u00e4ge unterst\u00fctzt von: AbbVie, Almiral, BMS, Celgene, Janssen, Leo-Pharma, Lilly, LaRoche-Possay, Novartis, MSD, Medac, Pfizer, Regeneron, Sanofi, Sandoz-Hexal, UCB. Mitglied des wissenschaftlichen Boards: AbbVie, Amgen, BMS, Celgene, Dignity, Eli-Lilly, Galapagos, Leo-Pharma, Janssen-Cilag, Morphosis, Novartis, Pfizer, MSD, Sandoz, Sanofi, UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}